Evaluation of information flows in the RAS-MAPK system using transfer entropy measurements

Area of Science:

• Cellular Signaling and Molecular Biology
• Systems Biology
• Pharmacology and Pathology

Background:

• The RAS-MAPK pathway is crucial for cellular processes like growth and differentiation, and its dysregulation is linked to cancer and genetic disorders.
• Understanding the intricate regulatory mechanisms within this pathway is essential for developing targeted therapies.

Purpose of the Study:

• To apply information flow analysis, specifically transfer entropy (TE), to elucidate the regulatory dynamics between SOS and RAF in the RAS-MAPK system.
• To explore the potential of TE as a model-free method for assessing information flow and identifying regulatory networks in cellular signaling.

Main Methods:

• Utilized transfer entropy (TE) to analyze the activation dynamics between SOS (guanine nucleotide exchanger for RAS) and RAF (RAS effector kinase) in EGF-stimulated cells.
• Employed a model-free approach to quantify the timing, direction, and strength of information flow within the cellular system.
• Validated TE findings using an MEK inhibitor and by analyzing a SOS mutation linked to Noonan syndrome.

Main Results:

• Detected significant bidirectional information flow (TE) between SOS and RAF, indicating feedback regulation within the RAS-MAPK pathway.
• Demonstrated that TE is a unique measure, independent of input dose or causal reaction intensity.
• Proposed a regulatory network model with multiple pathways and feedback loops, including temporal switching, which was experimentally confirmed.
• Identified a functional disorder in a SOS mutation associated with Noonan syndrome, shedding light on its pathogenic mechanism.

Conclusions:

• Transfer entropy is a powerful, model-free tool for dissecting complex regulatory networks in cellular signaling pathways like RAS-MAPK.
• TE analysis provides novel insights into pathway dynamics, feedback mechanisms, and the functional consequences of genetic mutations.
• This approach holds significant promise for advancing molecular pharmacology and understanding the pathology of diseases driven by signaling pathway dysregulation.